Share this:
While the number of COVID-19 cases continues to surge, there is positive news on the vaccine front. In early clinical trial data, two vaccines have now shown at least 90% effectiveness in reducing the risk of infection from the virus that causes COVID-19. While more time and research is needed to understand how long the immunity from a vaccine lasts, experts believe a vaccine could be approved for emergency use authorization before the end of the year.
On the Mayo Clinic Q&A podcast, Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group, discusses the latest on current COVID-19 clinical trials. Dr. Poland also explains what public health experts mean by community spread of the virus and why that leads to exponential growth in cases of COVID-19.
Research disclosures for Dr. Gregory Poland.
Information in this post was accurate at the time of its posting. Due to the fluid nature of the COVID-19 pandemic, scientific understanding, along with guidelines and recommendations, may have changed since the original publication date.
For more information and all your COVID-19 coverage, go to the Mayo Clinic News Network and mayoclinic.org.
